Natural Products Remain an Important Source for Drug Development in the Post-Genomic Era

MOJ Bioequivalence & Bioavailability
doi 10.15406/mojbb.2017.03.00049
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MedCrave Group, LLC